The current management of B-chronic lymphocytic leukemia (CLL) is no longer straightforward for the practicing hematologist. Rapid advances in diagnostic precision, methods of predicting prognosis, understanding of natural history of CLL, recognition of clinical complications, clarification of the quality of life (QOL) issues facing the CLL patient, and the exciting array of novel treatment approaches have made the care of the CLL patient more demanding. This review is focused on summarizing these advances in order to provide a framework for integrating this knowledge into routine hematologic practice.
IntroductionThe comprehensive approach to patients with B-chronic lymphocytic leukemia (CLL) now requires risk stratification for newly diagnosed patients, adherence to supportive care guidelines, attention to quality-of-life (QOL) issues specific to patients with CLL, and consideration of age, comorbidity, and QOL in selection of therapy and disease management. For this review we will emphasize how to translate the numerous recent advances in prognostic parameters, supportive care, and treatment into the care of individual patients with CLL.